<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852735</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0047</org_study_id>
    <secondary_id>AU 759</secondary_id>
    <nct_id>NCT00852735</nct_id>
  </id_info>
  <brief_title>Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases (Optim'Oils)</brief_title>
  <official_title>Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre de Recherche en Nutrition Humaine d'Auvergne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Recherche Agronomique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ITERG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lesieur</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of optimized oil (enriched with&#xD;
      micronutriments) on the prevention on cardiovascular diseases.&#xD;
&#xD;
      Randomised crossover dietary intervention study:&#xD;
&#xD;
      The main objective of the clinical study is to investigate the effect of the consumption of&#xD;
      an &quot;optimized&quot; rapeseed oil on the lipid metabolism of volunteers as compared with the&#xD;
      consumption of a &quot;reference&quot; oil.&#xD;
&#xD;
      Post prandial study:&#xD;
&#xD;
      The second objective of the clinical study is to investigate the effect of the consumption of&#xD;
      an &quot;optimized&quot; rapeseed oil on the biomarkers of oxidative stress during post prandial period&#xD;
      as compared with the consumption of a &quot;reference&quot; oil.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For both studies, sedentary men between 30 and 65 years of age, with a BMI between 25 and 30,&#xD;
      without cardiovascular disorders, will be selected.&#xD;
&#xD;
      Randomised crossover dietary intervention study:&#xD;
&#xD;
      Sixty volunteers will be randomised into 2 groups of 30. The study will last 12weeks. The&#xD;
      first 3 weeks will be an adaptation period or &quot;run in&quot;. Volunteers will have every day20 g of&#xD;
      the reference rapeseed oil and 20 g of the reference oil-based rapeseed margarine.&#xD;
      Subsequently, the two groups will follow 2 dietary intervention periods of 3 weeks during&#xD;
      which the volunteers will have alternatively either the reference oil/margarine or the&#xD;
      optimized oil/margarine. Three weeks of &quot;wash out&quot; will separate the two dietary&#xD;
      interventions of the cross over design trial.&#xD;
&#xD;
      Cardiovascular risk and oxidative stress biomarkers will be assessed in plasma at week 0, 3,&#xD;
      6, 9 and 12.&#xD;
&#xD;
      Volunteers will alsoperform dietary surveys at the week 3, 6, 9 and 12.&#xD;
&#xD;
      Post prandial study:&#xD;
&#xD;
      16 volunteers will be cast lots among the 60 volunteers. They will be randomised into 2&#xD;
      groups of 8. The first kinetic study will be done on week 3. 8 subjects will take 66 g of&#xD;
      reference oil and 8 subjects will take 66 g of the optimized oil. 5 blood samples (20 mL&#xD;
      each) will be taken.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HDL-Cholestérol</measure>
    <time_frame>study 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of the oxidative stress every 3 weeks Biomarkers of the oxidative stress during the post prandial period</measure>
    <time_frame>every 3 weeks, during the post prandial period</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Rapeseed Oil (prevention of cardiovascular diseases)</intervention_name>
    <description>to assess the effect of optimized oil (enriched with micronutriments) on the prevention on cardiovascular diseases</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Age : 30 to 65&#xD;
&#xD;
          -  Body mass index between 25 and 30 kg/m²&#xD;
&#xD;
          -  Weight lower than 110 kg&#xD;
&#xD;
          -  Subject considered as normal after clinical examination and medical questionnaire&#xD;
&#xD;
          -  Subject giving his written informed consent&#xD;
&#xD;
          -  Subject willing to comply with the study procedures&#xD;
&#xD;
          -  Affiliated to National Health Insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Biological results judged abnormal by investigator&#xD;
&#xD;
          -  Positive serologies to HIV or HCV&#xD;
&#xD;
          -  Previous medical and/or surgery judged by the investigator as incompatible with the&#xD;
             study&#xD;
&#xD;
          -  Taking medicine: hypocholesterolemic,beta blockers, IEC,&#xD;
&#xD;
          -  Diabetes1 and 2&#xD;
&#xD;
          -  High blood pressure&#xD;
&#xD;
          -  Digestive, cardiovascular, renal, liver, tumor or thyroid diseases in the last 5 years&#xD;
&#xD;
          -  Infectious or inflammatory diseases in the last 5 years&#xD;
&#xD;
          -  Previous heavy intestine surgery (except appendectomy)&#xD;
&#xD;
          -  Triglycerides&gt; 4 g/L&#xD;
&#xD;
          -  Dyslipidemia: HDL cholesterol&lt; 0.4 g/L or LDL/HDL&gt;6.25&#xD;
&#xD;
          -  blood donation done less than 2 month before the start of the study&#xD;
&#xD;
          -  Particular diet: vegetarian, vegan...&#xD;
&#xD;
          -  Anormal dietary habits&#xD;
&#xD;
          -  Consumption of food complements: antioxidant, ...&#xD;
&#xD;
          -  intense physical exercise practise (&gt;5 h per week)&#xD;
&#xD;
          -  Tobacco, alcohol:more than 30 g of alcohol/day, i.e.3 glasses/day, smoking &gt; 5&#xD;
             cigarettes /day&#xD;
&#xD;
          -  No affiliated to National Health Insurance people&#xD;
&#xD;
          -  Refusal to sign informed consent&#xD;
&#xD;
          -  Refusal to be registered on the National Volunteers Data file&#xD;
&#xD;
          -  Currently participating or who having got 4500 E in this year before to have&#xD;
             participated in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noël Cano</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Nutrition Humaine d'Auvergne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CRNH Auvergne</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>February 26, 2009</study_first_submitted>
  <study_first_submitted_qc>February 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2009</study_first_posted>
  <last_update_submitted>March 9, 2010</last_update_submitted>
  <last_update_submitted_qc>March 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Noël CANO</name_title>
    <organization>CRNH Auvergne</organization>
  </responsible_party>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Rapeseed oil</keyword>
  <keyword>Micronutriments</keyword>
  <keyword>HDL cholesterol</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Tocopherols</keyword>
  <keyword>Sterols</keyword>
  <keyword>Prevention of cardiovascular diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

